Seems the justification for asking for a randomised study was the failure of two previous randomised studies that occured a decade ago with different treatment regimens and the fact that the FDA couldn't work out what an appropriate null hypothesis is - seems flimsy to me and I guess 9 of the ODAC committee agreed that the FDA were barking up the wrong tree. Cest la vie I suppose
Seeking Alpha hatchet job, page-117
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.59 |
Change
0.015(0.96%) |
Mkt cap ! $1.764B | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.59 | $1.52 | $1.818M | 1.174M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 12801 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 43763 | 4 |
View Market Depth
| Last trade - 11.52am 18/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |